Blog - QualityStocks

ThursdayApr 17, 2025 3:25 pm

QualityStocksNewsBreaks – Nightfood Holdings Inc. (NGTF) Leading Hospitality Tech Revolution with Innovative Solutions

Nightfood Holdings (OTCQB: NGTF) is modernizing the hospitality industry with its AI-driven robotics solutions and innovative Robots-as-a-Service (“RaaS”) model, offered through subsidiaries Skytech and Future Hospitality Ventures. Addressing the ongoing labor crisis, NGTF enables hotel operators to integrate cutting-edge robotics without significant upfront costs. This model boosts operational efficiency and guest satisfaction while also creating customer-retention value and recurring revenue streams. With successful deployments in its first properties from InterContinental Hotels Group and Hilton Worldwide Holdings, as well as a rapidly expanding robotics portfolio, NGTF is positioned at the forefront of the service robotics market, which is projected to reach $107.75…

ThursdayApr 17, 2025 2:25 pm

QualityStocksNewsBreaks – SolarBank Corp.’s (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Vision in Action: Building the Grid of Tomorrow

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., is reinforcing its role in powering the future through solar, battery storage, and EV charging projects. In recent interviews on InvestorBrandNetwork’s Bell2Bell and Electrek’s Quick Charge podcasts, CEO Richard Lu highlighted the company’s vertically integrated model, strategic partnerships—including a $50 million contract with Qcells and a new collaboration with Viridi—and its robust project pipeline exceeding 1 gigawatt of capacity. SolarBank is currently advancing…

ThursdayApr 17, 2025 12:05 pm

QualityStocksNewsBreaks – ROTH Conference Marks a Quarter-Century of Community in Dana Point

The 37th Annual ROTH Conference drew thousands of participants from around the globe to Dana Point, California, the host location of the event for the past 25 years. In addition to a successful gathering of institutional investors, company executives, and industry visionaries, this year’s conference marked a milestone in Roth Capital Partners, LLC’s (“ROTH”) enduring commitment to the local community that has helped shape the event’s identity over the last quarter-century. “The Dana Point community has been an incredible partner to us over the last 25 years,” said ROTH CFO Gordon Roth. “We are honored and deeply grateful for the…

ThursdayApr 17, 2025 9:35 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Reports Record Attendance and Revenue Boost at Juve Stabia Derby

Brera Holdings (NASDAQ: BREA) announced that its Serie B club, S.S. Juve Stabia, achieved its highest home attendance of the season with 7,000 fans at the April 5 derby against Salernitana—just shy of a sellout at Stadio Romeo Menti. The turnout marks a key step in the club’s commercial strategy to boost matchday revenue and long-term fan engagement. Juve Stabia ranks 5th in Serie B and has seen its squad value surge 36.9% to €16.13 million, as Brera advances its multi-club ownership model through both on-field success and off-field monetization. To view the full press release, visit https://ibn.fm/29ELZ About Brera Holdings…

ThursdayApr 17, 2025 9:25 am

QualityStocksNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Receives FDA Clearance to Begin Trials for CLD-201 in Solid Tumors

Calidi Biotherapeutics (NYSE American: CLDI) announced FDA clearance of its Investigational New Drug application for CLD-201, an allogeneic stem cell-based virotherapy targeting solid tumors including breast cancer, head and neck cancer, and soft tissue sarcoma. Backed by preclinical data showing immune system evasion and potent tumor-killing ability, CLD-201 is now cleared to enter clinical development. The therapy combines adipose-derived stem cells with oncolytic vaccinia virus, representing a novel immunotherapeutic approach for hard-to-treat cancers. To view the full press release, visit: https://ibn.fm/362xV About Calidi Biotherapeutics Calidi Biotherapeutics specializes in proprietary technology that empowers the immune system to combat cancer. The company’s…

ThursdayApr 17, 2025 9:00 am

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Taps Data Center Veteran Jonathan Martone to Guide Data Center Market Expansion Strategy

Martone will assist with evaluating and sourcing U.S. and Canadian sites, focusing on power availability, connectivity, and operational feasibility. The move reflects SolarBank’s strategy to align with AI-driven data demand and to integrate clean energy solutions with digital infrastructure. The company has reaffirmed its U.S. focus to reduce exposure to tariffs on imports from China, Mexico, and Canada. SolarBank’s recent $49.8 million deal with Qcells underpins its commitment to “Made in America” infrastructure. Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in…

WednesdayApr 16, 2025 12:20 pm

QualityStocksNewsBreaks – ProPhase Labs Inc. (NASDAQ: PRPH) Closes $23.6M Sale to Focus on Core Businesses

ProPhase (NASDAQ: PRPH), a next-generation biotech, genomics, and diagnostics company, earlier this year announced the closing of the sale of its wholly owned subsidiaries, Pharmaloz Manufacturing Inc. and Pharmaloz Real Estate Holdings Inc. (collectively “Pharmaloz” or “PMI”), to a private equity group based in Houston, Texas. The transaction’s aggregate deal was valued at approximately $23.6 million, which immediately bolstered ProPhase’s balance sheet and liquidity by eliminating over $20 million in debt, payables, and other contingent liabilities. Overall, the transaction better positioned ProPhase to focus on its promising and high-value core businesses. To view the full press release, visit https://ibn.fm/ardt7 About…

WednesdayApr 16, 2025 9:00 am

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Advances Subsurface Imaging to Expand Montauban Project Potential

ESGold has completed data acquisition for a deep subsurface imaging survey at its Montauban Project in Quebec. The Ambient Noise Tomography (“ANT”) survey revealed imaging depths of over 800 meters—double the original plan. A 3D model integrating ANT data and historical information is in development to guide future drilling. The survey marks the first deep-sensing exploration campaign at Montauban, a fully permitted pre-production site. The company intends to begin production at Montauban in Q3 2025. Production is set to begin in the third quarter of 2025, with an initial throughput capacity of 500 tonnes per day, scalable to 1,000 tonnes.…

TuesdayApr 15, 2025 12:15 pm

QualityStocksNewsBreaks – EZCORP Inc. (NASDAQ: EZPW) Secures $300M in Private Offering

EZCORP (NASDAQ: EZPW), a leading provider of pawn transactions in the United States and Latin America, recently closed a private offering of $300 million of 7.375% senior notes due 2032. The company expects to use approximately $103.4 million of the net proceeds to repay its outstanding 2.375% convertible senior notes due 2025 at maturity. EZCORP intends to use any excess proceeds for general corporate purposes. Roth Capital Partners acted as co-manager for the transaction. For more information, visit https://ibn.fm/yVmWD About EZCORP Formed in 1989, EZCORP has grown into a leading provider of pawn transactions in the United States and Latin…

TuesdayApr 15, 2025 9:45 am

Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’

Nutriband’s AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, like fentanyl, while keeping these drugs accessible to patients. AVERSA technology can be incorporated into any transdermal patch. The company has a broad and expanding intellectual property portfolio protecting AVERSA, with patents granted in the U.S., Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China. Nutriband closed an $8.4 million financing round in April 2024 to support commercial development of AVERSA Fentanyl, its abuse-deterrent fentanyl transdermal patch. In February 2025, the company formalized a long-term exclusive partnership with Kindeva Drug Delivery to support…

Site Search

Company Search